| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.045 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |